Last spring, the FDA approved a new drug for breast cancer. It's expensive--about $2,900 per month. But what if it turned out that the cost could be cut by 80%, with a simple intervention that costs nothing? Join us to find out how it can be done, and how it could slash health care costs, not only for cancer treatment, but for treatment of other ailments as well. Hosted by Paul Raeburn.
ReachMD
Be part of the knowledge.™Cutting the Cost of Cancer Drugs
- Guest Ezra Cohen, MD
- Host Paul Raeburn
Last spring, the FDA approved a new drug for breast cancer. It's expensive--about $2,900 per month. But what if it turned out that the cost could b...
Recommended
Innovations In Medicine
Innovations In Medicine
Innovations In Medicine
Innovations In Medicine
Innovations In Medicine
Innovations In Medicine
- Diagnosis and Treatment of Diabetic Macular Edema
- A Chalkboard Approach to Updates in Cervical Cancer Screening
- The Experts Weigh in: Is Bacterial Vaginosis an STI?
- Skin Boosting Technique: A New Approach to Hyaluronic Acid Microinjection
- Resistance in Vulvovaginal Candidiasis (VVC) - A Growing Problem
- Multidisciplinary Teams for Psoriasis
- New Systemic Options for Managing cSCC: A Care Team Forum
- Diet and Nutrition in the Management of IBD
- Is Peanut Oral Immunotherapy a Safe & Effective Treatment?
- What the PsA LOOP Study Means for Dermatologists & Rheumatologists
- Reconsidering the Concept of First-Line, High-Efficacy Treatment
- Osteoarthritis: Not Just a Wear-and-Tear Problem
- Urothelial Carcinoma: Case Study on a Patient Who Is Platinum Ineligible
- A Treatment Strategy for Postmenopausal Women with Osteoporosis at High Risk for Fracture
- Selecting the RIGHT Patient for Systemic Therapy in cSCC: A Care Team Forum
- The New Trend in Primary Care: Screening for STIs
- Decoding HAC Scores: The Impact of Hospital-Acquired Conditions
- A Clinician’s Perspective – Managing Bacterial Vaginosis
- Closing the Circle in Hypoactive Sexual Desire Disorder: Communication, Diagnosis, and Treatment
- cSCC Patient Clinic
- Iron Sequestration in Microbiota Biofilms in Treatment for IBD
- Unmet Clinical Needs for Patients with T2D and Established CVD
- New Opportunities to Improve Management of Patients with or at High Risk of ASCVD Events
- Role of the Cardiologist in T2D Management
- Closing the Gap: Moving Towards Proactive IBD Management
- Challenges Faced in Vascular Access Care: A Patient Case
- Burning Debate: B cells vs. T cells
- The New Trend in Primary Care: Screening for STIs
- Urothelial Carcinoma: Case Study on Disease Progression After Platinum Chemotherapy
- Primary Care’s Skin in the Game: Psoriasis Identification, Treatment, and Referral Decisions
- The Health Maintenance Checklist for Your IBD Patients
- Multidisciplinary Teams for Psoriasis
- Pinpointing the Top Questions about Biosimilars in Rheumatology
- Is Peanut Oral Immunotherapy a Safe & Effective Treatment?
- Overcoming Obstacles in Treating Nonunion Fractures
- Changing the Approach to PsA: A Dermatologist’s Take on the LOOP Study
- Expanding Preterm Labor Assessment Evaluations with fFN Testing
- Switching the Setting of Gynecological Procedures
- Urothelial Carcinoma: Case Study on a Patient Who Is Platinum Ineligible
- Skin Boosting Technique: A New Approach to Hyaluronic Acid Microinjection
- Crohn’s & Colitis Congress: Nutritional Therapy for IBD: From Theory to Your Practice
- Comparing the AAD and NPF Psoriasis Guidelines
- So Cute You Could...Crush It?
- Sexual Health Impacts of Psoriasis
- A Treatment Strategy for Postmenopausal Women with Osteoporosis at High Risk for Fracture
- New Fibromyalgia Findings: What are the Experts Saying?
- Updates in Hemophilia: Making Headway in the Multidisciplinary Setting
- Guiding Breast Cancer Patients Through the Care Journey: Practice Pearls for PCPs
- The New Trend in Primary Care: Screening for STIs
- Making Sense of Competing Breast Cancer Treatment Recommendations
- Oncology On-Que: Expert Answers to Common Questions for Optimizing Platinum-Refractory NSCLC Treatment
- Precision Oncology: Incorporating Next Generation Sequencing (NGS) in NSCLC
- The New Trend in Primary Care: Screening for STIs
- Engaging the Nursing Community in Treatment of Opioid Use Disorder
- Reconsidering the Concept of First-Line, High-Efficacy Treatment
- Changing Course: Anticoagulation in Secondary Prevention of Cardiovascular Disease Events
- What is the Role for TKIs in RCC? Highlights from the 18th Annual Meeting of the SUO
- Uncontrolled Moderate-to-Severe-Asthma: Latest Data from the Floor of CHEST 2018
- Rheumatoid Arthritis: Counseling Women Who Are Trying to Conceive
- Opioid Use Disorder: Expanding Access to Treatment
- Blunt Tip Cannulas with Hyaluronic Acid Injections in the Face and Lip: Applying Theory in Practice
- The New Trend in Primary Care: Screening for STIs
- Special Patient Populations in MS: Utilizing Shared Decision-Making
- Vocal Variety: The 5 Ps to Avoiding Monotonous Speeches
- IBS-D: What to Do When Typical Treatment Methods Fail
- Switching the Setting of Gynecological Procedures
- New Directions on Therapeutic Drug Monitoring in IBD
- Addressing the Psychosocial Impacts of IBD
- Research Takeaways from the Crohn’s & Colitis Congress
- Unmet Clinical Needs for Patients with T2D and Established CVD
- New Systemic Options for Managing cSCC: A Care Team Forum
- The New Trend in Primary Care: Screening for STIs
- Bacterial Vaginosis & VVC: How Can We Improve Current Diagnosis Methods?
- Switching the Setting of Gynecological Procedures
- Role of the Cardiologist in T2D Management
- New Opportunities to Improve Management of Patients with or at High Risk of ASCVD Events
- Crohn’s & Colitis Congress: A Discussion About Diagnosing and Treating Pediatric IBD
- Hemophilia A - Making It Personal: A Patient Experience
- Crohn’s & Colitis Congress: What Advanced Practice Providers Need to Know on Optimal IBD Outcomes
- Minimizing Hospital-Acquired Conditions: A Focus on CLABSIs
- Raising Mental Health Awareness
- Urothelial Carcinoma: Case Study on Disease Progression After Platinum Chemotherapy
- What the PsA LOOP Study Means for Dermatologists & Rheumatologists
- Taking a Closer Look at Psoriasis Comorbidities
- From Neuropathology to New Pathophysiological Concepts and Clinical Perspectives
- Iron Sequestration in Microbiota Biofilms in Treatment for IBD
- Clinical Perspectives on Pregnancy and MS Patients
- Raising Awareness of Sickle Cell Disease
- Sexual Health Impacts of Psoriasis
- Diagnosis and Treatment of Diabetic Macular Edema
- cSCC Patient Clinic
- Multidisciplinary Teams for Psoriasis
- Closing the Gap: Moving Towards Proactive IBD Management
- Why Early Detection for Alzheimer's Disease is So Critically Important
- Resistance in Vulvovaginal Candidiasis (VVC) - A Growing Problem
- Clinical & Treatment Challenges of Seborrheic Keratosis: Still Stuck on the Surface of Care
- Socioeconomic Challenges for Psoriasis Patients
- Reconsidering the Concept of First-Line, High-Efficacy Treatment
- Switching the Setting of Gynecological Procedures
- Fluent: Untangling Fluid Management
- The New Trend in Primary Care: Screening for STIs
- Diet and Nutrition in the Management of IBD
- Decoding HAC Scores: The Impact of Hospital-Acquired Conditions
- Prednisone and Lupus – A Treatment Mainstay?
- A Chalkboard Approach to Updates in Cervical Cancer Screening
- Challenges Faced in Vascular Access Care: A Patient Case
- Expert Tips on Treating Genitourinary Syndrome of Menopause
- Selecting the RIGHT Patient for Systemic Therapy in cSCC: A Care Team Forum
- Unmet Clinical Needs for Patients with T2D and Established CVD
- Burning Debate: B cells vs. T cells
- The Impact of the LOOP Study on PsA: A Rheumatologist’s Take
- Osteoarthritis: Not Just a Wear-and-Tear Problem
- Changing the Approach to PsA: A Dermatologist’s Take on the LOOP Study
- Primary Care’s Skin in the Game: Psoriasis Identification, Treatment, and Referral Decisions
You must be logged in to display playlists.
Facebook Comments